Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Optimal Frequency to Screen Celiac Disease Amongst Patients With Type 1 Diabetes Mellitus: A Multicenter Study Publisher Pubmed



Moravej H1, 2 ; Zamanfar D3 ; Aghamahdi F4 ; Hashemipour M5 ; Mirrashidi FS6 ; Ghaemi N7 ; Eshraghi P7 ; Ilkhanipoor H2 ; Amirhakimi A2 ; Yazdani N1 ; Asl SN7 ; Hashemian S8 ; Raoofat A9 ; Vazirian MV10 Show All Authors
Authors
  1. Moravej H1, 2
  2. Zamanfar D3
  3. Aghamahdi F4
  4. Hashemipour M5
  5. Mirrashidi FS6
  6. Ghaemi N7
  7. Eshraghi P7
  8. Ilkhanipoor H2
  9. Amirhakimi A2
  10. Yazdani N1
  11. Asl SN7
  12. Hashemian S8
  13. Raoofat A9
  14. Vazirian MV10
  15. Ebrahimzadeh H2

Source: Primary Care Diabetes Published:2021


Abstract

Aims: Celiac disease (CD) is frequent amongst patients with type 1 diabetes mellitus (T1DM). Since there is a disagreement on the optimal interval and frequency to perform screening tests for CD among diabetic patients, this study aimed to evaluate these issues amongst patients with T1DM. Methods: This retrospective cohort study was conducted in seven referral diabetic centers in different cities of Iran from January 2020 to January 2021. Data belonging to 106 patients who were affected by both T1DM and CD was collected. The time interval between CD diagnosis and diabetes (IBCD), the age of diabetes onset, and any associated diseases, symptoms, and family history of T1DM and CD were recorded and analyzed. Results: Results show that 45% of the patients with CD were diagnosed during the first year of diabetes onset; furthermore, 18% and 16% of the patients with CD were diagnosed in the second or third year after being diagnosed with diabetes. In addition, another 18% of patients with CD were diagnosed during the fourth till the eighth year after diabetes onset. Moreover, there was a negative relationship between the age of T1DM diagnosis and IBCD. Most participants were asymptomatic at the time of CD diagnosis. Conclusions: Screening tests to detect CD amongst patients with T1DM should continue for at least eight years after the initial T1DM diagnosis, especially those affected at a younger age. © 2021 Primary Care Diabetes Europe
Other Related Docs
7. Vitiligo and Autoantibodies of Celiac Disease, International Journal of Preventive Medicine (2013)
11. Risk of Diabetes in Combined Metabolic Abnormalities and Body Mass Index Categories, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2016)
16. The Frequency Distribution of Celiac Autoantibodies in Alopecia Areata, International Journal of Preventive Medicine (2016)